Weekly Roundup for OCTOBER 21, 2022: Recent Publications in Women’s Mental Health
Every week we review the most recent publications in women’s mental health.
Largest Study Ever Shows No Increase in Risk of Neurodevelopmental Disorders in Kids Exposed to Antidepressants In Utero
Analyzing data from nearly 150,000 children with prenatal antidepressant exposure in two healthcare databases, a recent study finds no association between prenatal exposure to antidepressants and risk for neurodevelopmental disorders.
Depression and Anxiety Common After Stillbirth, Particularly in Women Without Partner Support
Depression and anxiety are prevalent among women who have experienced a stillbirth, especially those reporting inadequate paternal support
Prevalence of Bipolar Disorder and Bipolar-Spectrum Mood Episodes During Pregnancy and the Postpartum Period in Perinatal Women
A recent review and meta-analysis found that upwards of 20% of women with no history of psychiatric illness experience their first bipolar-spectrum mood episode during the perinatal period.
Maternal Adverse Childhood Experiences Linked to Changes in Neonatal Brain Development and Behavior
Maternal ACEs were associated with both newborn amygdala volume and subsequent infant negative emotionality.
Postpartum psychosis: Does longitudinal course inform treatment?
Dr. Lee S. Cohen, Director of the Ammon-Pinizzotto Center for Women's Mental Health at Massachusetts General Hospital, recently shared his insights on clinical issues regarding prescribing antidepressants during pregnancy with Ob.Gyn News on August 16, 2022. The last 15 years have brought increased effort to screen for postpartum psychiatric illness. That’s exceedingly welcome given the morbidity and potential mortality associated with postpartum psychiatric disorders across the country. From small community hospitals [...]